Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Please note that all translations are automatically generated. Click here for the English version.
1.7K Views
•
12:53 min
•
March 16th, 2022
DOI :
March 16th, 2022
•Przeglądaj więcej filmów
Rozdziały w tym wideo
0:04
Introduction
1:00
Cell‐Free Production of MOMP‐tNLPs for Subunit Vaccine Formulations
4:21
MOMP‐tNLP Purification
7:19
Western and Dot Blots and Storage
10:14
Results: SDS‐PAGE Analysis
11:46
Conclusion
Powiązane Filmy
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
10.4K Views
10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
12.5K Views
00:10
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
7.5K Views
13:53
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
4.9K Views
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
10.6K Views
09:03
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
8.6K Views
08:07
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
2.5K Views
10:32
Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
4.2K Views
06:38
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
899 Views
06:17
Expression and Purification of Virus-like Particles for Vaccination
21.8K Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone